(Q34321603)

1 August 2017

1 reference

title

Type 1 diabetes: new perspectives on disease pathogenesis and treatment (English)

1 reference

1 August 2017

0 references

0 references

2

G S Eisenbarth

1 reference

1 August 2017

M A Atkinson

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

358

1 reference

1 August 2017

issue

9277

1 reference

1 August 2017

page(s)

221-229

1 reference

Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The pathogenesis of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

New insights into the epidemiology of type 1 diabetes in Mediterranean countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Sometimes it's hot, sometimes it's not

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Human type 1 diabetes and the insulin gene: principles of mapping polygenes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Early infant diets and insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Viruses and other perinatal exposures as initiating events for beta-cell destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Environmental factors in the pathogenesis of type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Lack of association between early childhood immunizations and beta-cell autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Genes versus environment in insulin-dependent diabetes: the phoney war.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Non-specific viral infections as possible synchronising events of the manifestation of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Infections and risk of Type I (insulin-dependent) diabetes mellitus in Lithuanian children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Prevention of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Safety of high-dose nicotinamide: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Thyroid autoimmunity in insulin-dependent diabetes mellitus: The case for routine screening

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Association of insulin-dependent diabetes mellitus and celiac disease: a study based on serologic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Celiac disease in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Transglutaminase antibodies in children with a genetic risk for celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Addison's disease--serological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Geographic variation in mortality among individuals with youth-onset diabetes mellitus across the world. DERI Mortality Study Group. Diabetes Epidemiology Research International

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Effectiveness of postprandial Humalog in toddlers with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

1 reference

7 January 2021

Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Prevention of recurrent hypoglycemia in type 1 diabetes by pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Islet cell transplantation: the future?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Glucose-dependent insulin release from genetically engineered K cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

The role of digital fundus photography in diabetic retinopathy screening. Digital Diabetic Screening Group (DDSG).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Renoprotection in diabetes: genetic and non-genetic risk factors and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

Assessment and management of foot disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905415-0

7 January 2021

10.1016/S0140-6736(01)05415-0

Identifiers

DOI

1 reference

1 August 2017

1 reference